Physiologically based pharmacokinetics modeling in biopharmaceutics: case studies for establishing the bioequivalence safe space for innovator and generic drugs
D Wu, M Sanghavi, S Kollipara, T Ahmed… - Pharmaceutical …, 2023 - Springer
For successful oral drug development, defining a bioequivalence (BE) safe space is critical
for the identification of newer bioequivalent formulations or for setting of clinically relevant in …
for the identification of newer bioequivalent formulations or for setting of clinically relevant in …
[HTML][HTML] Advancing virtual bioequivalence for orally administered drug products: methodology, real-world applications and future outlook
S Kollipara, FS Martins, R Jereb, D Krajcar, T Ahmed - Pharmaceuticals, 2024 - mdpi.com
Bioequivalence studies are pivotal in generic drug development wherein therapeutic
equivalence is provided with an innovator product. However, bioequivalence studies …
equivalence is provided with an innovator product. However, bioequivalence studies …
Integration of Biorelevant Pediatric Dissolution Methodology into PBPK Modeling to Predict In Vivo Performance and Bioequivalence of Generic Drugs in Pediatric …
This study investigated the impact of gastro-intestinal fluid volume and bile salt (BS)
concentration on the dissolution of carbamazepine (CBZ) immediate release (IR) 100 mg …
concentration on the dissolution of carbamazepine (CBZ) immediate release (IR) 100 mg …
AI empowering traditional Chinese medicine?
For centuries, Traditional Chinese Medicine (TCM) has been a prominent treatment method
in China, incorporating acupuncture, herbal remedies, massage, and dietary therapy to …
in China, incorporating acupuncture, herbal remedies, massage, and dietary therapy to …
Delineating gene–environment effects using virtual twins of patients treated with clozapine
Studies that focus on individual covariates, while ignoring their interactions, may not be
adequate for model‐informed precision dosing (MIPD) in any given patient. Genetic …
adequate for model‐informed precision dosing (MIPD) in any given patient. Genetic …
A Rational approach to predicting immediate release formulation behavior in multiple gastric motility patterns: a combination of a biorelevant apparatus, design of …
Gastric mechanical stress often impacts drug dissolution from solid oral dosage forms, but in
vitro experiments cannot recreate the substantial variability of gastric motility in a reasonable …
vitro experiments cannot recreate the substantial variability of gastric motility in a reasonable …
PBBM Considerations for Base Models, Model Validation, and Application Steps: Workshop Summary Report
T Heimbach, F Musuamba Tshinanu… - Molecular …, 2024 - ACS Publications
The proceedings from the 30th August 2023 (Day 2) of the workshop “Physiologically Based
Biopharmaceutics Models (PBBM) Best Practices for Drug Product Quality: Regulatory and …
Biopharmaceutics Models (PBBM) Best Practices for Drug Product Quality: Regulatory and …
[HTML][HTML] Conjunction of semi-mechanistic in vitro-in vivo modeling and population pharmacokinetics as a tool for virtual bioequivalence analysis-a case study for a …
D Danielak, J Paszkowska, M Staniszewska… - European Journal of …, 2023 - Elsevier
Virtual bioequivalence trial (VBE) simulations based on (semi) mechanistic in vitro-in vivo
(IVIV) modeling have gained a huge interest in the pharmaceutical industry. Sophisticated …
(IVIV) modeling have gained a huge interest in the pharmaceutical industry. Sophisticated …
Application of a novel PhysioCell apparatus for biopredictive dissolution tests of oral immediate release formulations–A case study workflow for in vitro-in vivo …
M Romański, M Staniszewska, J Paszkowska… - International Journal of …, 2023 - Elsevier
Biorelevant dissolution tests of oral solid dosage forms open the gate to valid in vitro-in vivo
predictions (IVIVP). A recently developed apparatus, PhysioCell, allows mimicking the fluid …
predictions (IVIVP). A recently developed apparatus, PhysioCell, allows mimicking the fluid …
Optimization of oral isavuconazole dose for population in special physiological or pathological state: a physiologically based pharmacokinetics model-informed …
J Zhou, B Xu, Y Zheng, H Huang, Z Wei… - Journal of …, 2024 - academic.oup.com
Objective To recommend precision dosing and improve therapeutic efficacy against invasive
fungal disease, a physiologically based pharmacokinetic model (PBPK) of oral …
fungal disease, a physiologically based pharmacokinetic model (PBPK) of oral …